The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
The intrinsic antinociceptive effects of oxycodone appear to be κ -opioid receptor mediated
Abstract
Our previous studies in the Sprague-Dawley rat showed that the intrinsic antinociceptive effects of oxycodone are naloxone reversible in a manner analogous to morphine but that in contrast to morphine, oxycodone's antinociceptive effects have a rapid onset of maximum effect (approximately 5-7 min compared to 30-45 min for morphine), comprise one antinociceptive phase (compared to two phases) and are of relatively short duration (approximately 90 min compared to approximately 180 min). In the present study, administration of a range of selective opioid receptor antagonists has shown that the intrinsic antinociceptive effects of oxycodone (171 nmol) are not attenuated by i.c.v. administration of (i) naloxonazine, a mu1-selective opioid receptor antagonist, or (ii) naltrindole, a delta-selective opioid receptor antagonist, in doses that completely attenuated the intrinsic antinociceptive effects of equipotent doses of the respective mu- and delta-opioid agonists, morphine and enkephalin-[D-Pen(2,5)] (DPDPE). Although beta-funaltrexamine (beta-FNA) attenuated the antinociceptive effects of oxycodone (171 nmol i.c.v.), it also attenuated the antinociceptive effects of morphine and bremazocine (kappa-opioid agonist) indicative of non-selective antagonism. Importantly, the antinociceptive effects of oxycodone (171 nmol i.c.v.) were markedly attenuated by the prior i.c.v. administration of the selective kappa-opioid receptor antagonist, norbinaltorphimine (nor-BNI), in a dose (0.3 nmol) that did not attenuate the antinociceptive effects of an equipotent dose of i.c.v. morphine (78 nmol). Taken together, these data strongly suggest that the intrinsic antinociceptive effects of oxycodone are mediated by kappa-opioid receptors, in contrast to morphine which interacts primarily with mu-opioid receptors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A METHOD FOR DETERMINING LOSS OF PAIN SENSATION
D'AMOUR, F. E., & SMITH, D. L. (1941) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)03823-6 · Cited by 3,231
U-50,488: a selective and structurally novel non-Mu (kappa) opioid agonist.
Vonvoigtlander, P. F., Lahti, R. A., & Ludens, J. H. (1983) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)33422-1 · Cited by 805
Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors.
Raynor, K., Kong, H., Chen, Y., Yasuda, K., Yu, L., Bell, G. I., & Reisine, T. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09932-8 · Cited by 665
Naltrindole, a highly selective and potent non-peptide δ opioid receptor antagonist
Portoghese, P. S., Sultana, M., & Takemori, A. E. (1988) · European Journal of Pharmacology · doi:10.1016/0014-2999(88)90502-x · Cited by 612
Takemori, A. E., Ho, B. Y., Naeseth, J. S., & Portoghese, P. S. (1988) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21011-4 · Cited by 409
Minireview: Multiple MU opiate receptors
Pasternak, G. W., & Wood, P. J. (1986) · Life Sciences · doi:10.1016/0024-3205(86)90217-1 · Cited by 347
Morphine-3-glucuronide - a potent antagonist of morphine analgesia
Smith, M. T., Watt, J. A., & Cramond, T. (1990) · Life Sciences · doi:10.1016/0024-3205(90)90619-3 · Cited by 337
Self-citationPortoghese, P. S., Sultana, M., Nagase, H., & Takemori, A. E. (1988) · Journal of Medicinal Chemistry · doi:10.1021/jm00397a001 · Cited by 302
Mu receptor binding of some commonly used opioids and their metabolites
Chen, Z. R., Irvine, R. J., Somogyi, A. A., & Bochner, F. (1991) · Life Sciences · doi:10.1016/0024-3205(91)90150-a · Cited by 255
Emmerson, P. J., Liu, M. R., Woods, J. H., & Medzihradsky, F. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24051-4 · Cited by 232
Cited by
Regulation of μ-opioid receptors: desensitization, phosphorylation, internalization, and tolerance
Williams, J. T., Ingram, S. L., Henderson, G., Chavkin, C., von Zastrow, M., Schulz, S., Koch, T., Evans, C. J., & Christie, M. J. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.005942 · Cited by 802
Abram, S. E. (2007) · Yearbook of Anesthesiology and Pain Management · doi:10.1016/s1073-5437(08)70202-x · Cited by 318
L??tsch, J., Skarke, C., Liefhold, J., & Geisslinger, G. (2004) · Clinical Pharmacokinetics · doi:10.2165/00003088-200443140-00003 · Cited by 256
Pharmacology of opioids in the treatment of chronic pain syndromes
Vallejo, R. (2011) · Pain Physician · doi:10.36076/ppj.2011/14/e343 · Cited by 124
Nakamura, A., Yasufuku, K., Shimada, S., Aritomi, H., Furue, Y., Chiba, H., Muramoto, M., Takase, K., Koike, K., Matsumoto, T., et al. (2020) · Neuroscience Letters · doi:10.1016/j.neulet.2020.135177 · Cited by 9
Metadata
- Authors
- Ross, F. B., & Smith, M. T.
- Venue
- Pain
- Published
- 1997-11
- Volume
- 73
- Issue
- 2
- Pages
- 151-157
- ISSN
- 0304-3959 (ISSN-L)
- OpenAlex
- W2072800295
- Cited by
- 259
- References
- 19
- FWCI
- 1.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The intrinsic antinociceptive effects of oxycodone appear to be κ -opioid receptor mediated. https://app.cochat.ai/papers/10.1016/s0304-3959(97)00093-6
- The paper
- Ross, F. B., & Smith, M. T. (1997). The intrinsic antinociceptive effects of oxycodone appear to be κ -opioid receptor mediated. Pain. https://doi.org/10.1016/s0304-3959(97)00093-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.